Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Chemoradiotherapy Versus Chemotherapy, Which One Is Better for Resectable Gastric Cancer Patients?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20.

    Article  CAS  Google Scholar 

  2. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725–30.

    Article  CAS  Google Scholar 

  3. Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715–21.

    Article  CAS  Google Scholar 

  4. Lu HW, Sun YM, Zhu ZR, et al. Effect of chemoradiotherapy on the survival of resectable gastric cancer patients: a systemic review and meta-analysis. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12005-1.

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology and General Surgery, The First Hospital of China Medical University; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors (China Medical University), Ministry of Education, Heping District, Shenyang, People’s Republic of China

    Huiwen Lu MD, Yimeng Sun MD, Zirui Zhu MD, Junqiao Yao MD, Huimian Xu MD, PhD & Baojun Huang MD, PhD

  2. Department of Clinical Medicine of Year 2017, Dalian Medical University, Dalian, People’s Republic of China

    Rui Huang MD

Authors
  1. Huiwen Lu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yimeng Sun MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zirui Zhu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Junqiao Yao MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Huimian Xu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rui Huang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Baojun Huang MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Baojun Huang MD, PhD.

Ethics declarations

Disclosure

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lu, H., Sun, Y., Zhu, Z. et al. ASO Author Reflections: Chemoradiotherapy Versus Chemotherapy, Which One Is Better for Resectable Gastric Cancer Patients?. Ann Surg Oncol 29, 6976–6977 (2022). https://doi.org/10.1245/s10434-022-12023-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12023-z

Search

Navigation